THE SIGAL SMS HIGHLIGHTS OF 2022

A throwback at 2022 show the highlights of 2022.

Last year, we grew faster than ever before. Five new study sites joined our network. Together we performed 49 trials and randomised 1.541 patients – 5 times we included the first patient in Germany.

With our partners we built the SIGAL SMS network of study sites, doctors and sponsors to advance outpatient clinical research throughout Germany with 25 therapeutic areas, and a databank of 688.000 Patients.

Thank you for a successful 2022!

We look forward to creating new highlights with you and making research as easy and successful as possible in 2023 and beyond.